EMAM
Encompass More Asset Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
2,969
-2,922
| -50% | -$324K | 0.08% | 155 |
|
|
2025
Q1 | $660K | Buy |
5,891
+7
| +0.1% | +$784 | 0.2% | 100 |
|
|
2024
Q4 | $544K | Buy |
5,884
+1,066
| +22% | +$98.5K | 0.18% | 104 |
|
|
2024
Q3 | $404K | Buy |
4,818
+524
| +12% | +$43.9K | 0.15% | 114 |
|
|
2024
Q2 | $295K | Buy |
4,294
+427
| +11% | +$29.3K | 0.21% | 72 |
|
|
2024
Q1 | $283K | Buy |
3,867
+1,166
| +43% | +$85.4K | 0.23% | 70 |
|
|
2023
Q4 | $219K | Buy |
+2,701
| New | +$219K | 0.25% | 83 |
|